Loading...
'OvMark': a user-friendly system for the identification of prognostic biomarkers in publically available ovarian cancer gene expression datasets
Madden, Stephen F Clarke, Colin Stordal, Britta Carey, Mark S Broaddus, Russell Gallagher, William M Crown, John Mills, Gordon B Hennessy, Bryan T
Madden, Stephen F
Clarke, Colin
Stordal, Britta
Carey, Mark S
Broaddus, Russell
Gallagher, William M
Crown, John
Mills, Gordon B
Hennessy, Bryan T
Advisors
Editors
Other Contributors
Departments
Date
2014-10-24
Date Submitted
Keywords
OVARIAN CANCER
DIAGNOSIS
GENETICS
DIAGNOSIS
GENETICS
Other Subjects
Subject Mesh
Planned Date
Start Date
Collaborators
Principal Investigators
Alternative Titles
Publisher
Abstract
Abstract Background Ovarian cancer has the lowest survival rate of all gynaecologic cancers and is characterised by a lack of early symptoms and frequent late stage diagnosis. There is a paucity of robust molecular markers that are independent of and complementary to clinical parameters such as disease stage and tumour grade. Methods We have developed a user-friendly, web-based system to evaluate the association of genes/miRNAs with outcome in ovarian cancer. The OvMark algorithm combines data from multiple microarray platforms (including probesets targeting miRNAs) and correlates them with clinical parameters (e.g. tumour grade, stage) and outcomes (disease free survival (DFS), overall survival). In total, OvMark combines 14 datasets from 7 different array platforms measuring the expression of ~17,000 genes and 341 miRNAs across 2,129 ovarian cancer samples. Results To demonstrate the utility of the system we confirmed the prognostic ability of 14 genes and 2 miRNAs known to play a role in ovarian cancer. Of these genes, CXCL12 was the most significant predictor of DFS (HR = 1.42, p-value = 2.42x10−6). Surprisingly, those genes found to have the greatest correlation with outcome have not been heavily studied in ovarian cancer, or in some cases in any cancer. For instance, the three genes with the greatest association with survival are SNAI3, VWA3A and DNAH12. Conclusions/Impact OvMark is a powerful tool for examining putative gene/miRNA prognostic biomarkers in ovarian cancer (available at http://glados.ucd.ie/OvMark/index.html). The impact of this tool will be in the preliminary assessment of putative biomarkers in ovarian cancer, particularly for research groups with limited bioinformatics facilities.
Language
en